NCI Community Oncology Research Program - Kansas City (NCORP-KC)
NCI Community Oncology Research Program - Kansas City (NCORP-KC)




CCDR Clinical Trials

GI
Multiple Sites

SWOG S1415CD - "A Pragmatic Trial to Evaluate a Guideline Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as Prophylaxis for Patients Receiving Chemotherapy with Intermediate Risk for Febrile Neutropenia –Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)". This trial is only open for Research Medical Center, Menorah Medical Center and Centerpoint Medical Center.

CANCER TYPE: Multiple Sites
RESEARCH BASE: SWOG
NCT NUMBER: NCT02728596
Protocol Summary: VIEW SUMMARY
Consent Form: VIEW CONSENT FORM
UPDATED ON 09/26/2018 (20:43:32)

Patient Brochure: VIEW PATIENT BROCHURE
UPDATED ON 09/19/2018 (20:04:43)

BRIEF DESCRIPTION

Colony Stimulating Factor prophylaxis in pts with any stage breast, non-small cell lung or colorectal cancer, receiving chemo w/intermediate risk for febrile neutropenia.  DCP-001 Eligible









  © 2013-2019 All Rights Reserved. Privacy Policy | Terms & Conditions
NCI Community Oncology Research Program - Kansas City (NCORP-KC)
Questions? Call: +1-913-948-5588 | Contact Us
4121 W. 83rd St., Suite 259 Prairie Village, KS 66208 USA